Jack Kaye

Insider Reports History

Entity
Individual
Location
C/O Keryx Biopharmaceuticals, 750 Lexington Avenue, New York, US
Signature
/s/ Ping Rawson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jack Kaye:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DYADIC INTERNATIONAL INC Director Common Stock 59.6K $86.5K $1.45 Mar 5, 2025 Direct
uniQure N.V. Director Ordinary Shares 14.6K $70.1K $4.81 Jun 19, 2024 Direct
DYADIC INTERNATIONAL INC Director Restricted Stock Unit 21.6K $20.9K $0.97 Jan 2, 2025 Direct
uniQure N.V. Director Stock Option (Right to Buy) 15.8K Jun 19, 2024 Direct
DYADIC INTERNATIONAL INC Director Stock Option 0 Mar 5, 2025 Direct

Insider Reports Filed by Jack Kaye

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DYAI DYADIC INTERNATIONAL INC Mar 5, 2025 5 $0.35 4 Mar 7, 2025 Director
DYAI DYADIC INTERNATIONAL INC Jan 2, 2025 4 $0 4 Jan 7, 2025 Director
QURE uniQure N.V. Jun 19, 2024 2 $0 4 Jun 21, 2024 Director
QURE uniQure N.V. Jun 13, 2024 1 -$11.4K 4 Jun 17, 2024 Director
DYAI DYADIC INTERNATIONAL INC Jan 2, 2024 4 $0 4 Jan 4, 2024 Director
QURE uniQure N.V. Dec 31, 2023 2 $0 5 Feb 6, 2024 Director
QURE uniQure N.V. Jun 13, 2023 3 -$43.2K 4 Jun 20, 2023 Director
QURE uniQure N.V. Feb 27, 2023 1 -$7.68K 4 Mar 1, 2023 Director
DYAI DYADIC INTERNATIONAL INC Jan 3, 2023 2 $0 4 Jan 5, 2023 Director
DYAI DYADIC INTERNATIONAL INC Dec 31, 2022 2 $0 5 Jan 5, 2023 Director
QURE uniQure N.V. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
DYAI DYADIC INTERNATIONAL INC Jun 10, 2022 1 $0 4 Jun 14, 2022 Director
QURE uniQure N.V. Feb 28, 2022 1 -$10.1K 4 Mar 2, 2022 Director
QURE uniQure N.V. Feb 24, 2022 2 $0 4 Feb 28, 2022 Director
DYAI DYADIC INTERNATIONAL INC Jan 3, 2022 1 $0 4 Jan 5, 2022 Director